Conference Menu

Overview
Pre-Conference Workshop
Day 1
Day 2
User Group Meetings
PDF Download
Register
Hotel & Travel
Poster
Sponsor
Press Pass
Request Brochure
Send to a Colleague
HCA USA event

Corporate Sponsors:

 

Lead Sponsoring Publication:

 

 Sponsoring Publications:

 

USER GROUPS



 24 September

12:30-13:00 User Group Meeting Registration

Sponsored by:

13:00-17:00 Cellomics Products European User Group Meeting

  • The Thermo Fisher Scientific Cellomics HCS Products User Group meetings are designed for end users of Cellomics products to; 1.) interact with other end users and the Cellomics team; 2.) learn about techniques in HCS and cell biology; 3.) to drive assay development inside their organization.
  • People who attend the meeting will hear from other leading industry and academic scientists regarding their work using Cellomics HCS products. The presentations cover a broad spectrum of cell biology and are geared toward how they approached the problem and ultimately implemented Cellomics tools for discovery.
  • Technical information along with Tips and Tricks are shared from current Thermo Fisher HCS experts in a fun yet informative program.
  • Finally, Cellomics provides a fun, casual event that permits informal discussion with the entire Cellomics team and other HCS colleagues.

To register, please visit: www.cellomics.com/usergroup/site/eu_07/register_07.php

For updated agenda, please visit: www.cellomics.com/usergroup/site/eu_07/agenda1.html

 


26 September
12:30-13:00 Registration for User Group Meetings

13:00-17:00 Concurrent User Group Meetings



Click here for full program and abstracts

BD Bioimaging
Techology Workshop

13:00 Enabling Discovery Through Automated Imaging
Mindy Goldsborough, R&D Director, BD Bioimaging

13:30 Genome-Wide RNAi Screening Defines Factors Regulating Distinct Cell Morphology
Florian Fuchs, German Cancer Research Center, Research Group Signaling and Functional Genomics, Heidelberg, Germany

14:00 Real-Time High-Content Analysis of Cell Death: Multiplexing Caspase Activity, Propidium Iodide Accumulation and Nuclear Morphology Imaging for Multi-Parameter Time Course Analysis of Cell Death
David Jamieson, Newcastle University, UK

14:30 Refreshment Break

15:00 BD Discovery Platform - Enabling Technologies for Cell-Based Assays
Mary K. Meyer, Director, Cell and Tissue Technologies, BD Technologies, NC, USA

15:30 Characterization and Classification of Mitotis Interacting Agents Using High Content Imaging
Géraldine Penarier, Sanofi-Aventis, Oncology Research, Montpellier, France

16:00 New Software Features High-Content Analysis with BD Pathway
Thomas Horn, Applications Consultant, BD Bioimaging

17:00 Discussion Forum & Concluding Remarks

For more information or to register, please visit:
www.bdbeurope.com/url/1912.url


PerkinElmer / Evotec Technologies
User Group Meeting

PerkinElmer cordially invites you to our first European Opera User Group Meeting. Scientists from industry and academia will talk about how the Opera is used to understand molecular mechanisms in cellular research and how to find more specific drugs in cancer research and infectious diseases.Come and learn about how they apply confocal imaging to compound and RNAi screening. The high speed of the Opera and the unrivalled flexibility of the Acapella image analysis software for multiparametric approaches to high content screening will be elucidated.

13:00 Welcome Remarks
Gabriele Gradl, PerkinElmer

13:15 A New Member in the Opera Family
Gabriele Gradl, PerkinElmer

13:50 A High-Content Approach for the Identification of Genotype Selective Anti-Tumor Drugs Using Synthetic Lethal Screening in Human Tumor Cells
Iris Schmitt, Evotec AG

14:25 Understanding Molecular Mechanisms Underlying the Pathogen-Triggered PEN1 Focal Accumulation at Fungal Entry Sites
Dorit Meyer, Max Planck Institute for Breeding Research Cologne

15:00 Refreshment Break

15:30 Title to Be Announced
Marnix Van Loock, Tibotec

16:05 High-Content RNAi Screening for Genome-Wide Functional Analysis to Identify Novel Regulators of Endocytotic Pathways
Martin Stoeter, Max Planck Institute of Molecular Cell Biology and Genetics

16:40 Concluding Remarks

For more information or to register, please visit: www.perkinelmer.com/HCAeurope07


 

foot.jpg